| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $462K | -18.7% | -78.9% |
| SG&A Expense | $2.0M | +1.3% | +31.6% |
| Operating Income | -$2.4M | +3.2% | +33.9% |
| Pre-tax Income | -$2.3M | -146.8% | +51.4% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$2.3M | -146.8% | +44.3% |
| EPS (Basic) | -$0.14 | -133.3% | +61.1% |
| EPS (Diluted) | -$0.14 | -133.3% | +61.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.7M | +10.7% | +68.9% |
| Current Assets | $19.2M | +11.1% | +60.9% |
| Total Assets | $68.5M | +2.9% | +11.9% |
| Current Liabilities | $1.3M | +3.1% | -34.9% |
| Total Liabilities | $3.6M | -4.3% | -60.4% |
| Stockholders' Equity | $64.9M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.2M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $3.7M | — | — |
| +24.5% |